Investment company C100 announces that a European patent held by the wholly owned subsidiary Hunter Capital Dry Eye IPR has been registered with unitary effect at the European Patent Office. The patent is therefore covered by the unitary European patent system and is valid in 18 participating EU member states, including Sweden, Germany, France and Italy.